Press Releases
Aigenpulse launches CytoML 5.2: automated flow cytometry with unbiased analysis
Aigenpulse has rolled out an update to its CytoML Experiment Suite – its automated, end-to-end, machine learning solution specifically aimed at streamlining and automating...
News
MedMinder Appoints David J. Shulkin, M.D. Chairman of the Board of Directors
MedMinder Systems Inc., the leading fully integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients, announced the appointment of...
IT & Data Management
Paradigm4 unveils new analytical development data management tool to unlock allotrope data format ‘Treasure Trove’
Paradigm4 unveiled its scalable solution for efficiently working with the Allotrope Data Format (ADF) at the Allotrope Foundation’s Spring Connect meeting (19-26th April 2021).
Addressing...
Clinical Trials
Kintor Pharmaceuticals Announces Successful Proxalutamide COVID-19 Phase III Clinical Trial Initiation and Patient Dosing in U.S.
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the phase III clinical trial of proxalutamide for...
News
Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India
Gilead Sciences, Inc. announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners...
News
U.S. Resumes Use of Johnson & Johnson COVID Vaccine
The FDA and Centers for Disease Control lifted their recommended pause of the Johnson & Johnson coronavirus vaccine, with no restrictions on who can...
Press Releases
Samsung Biologics and TG Therapeutics Expand Collaboration for the Large Scale Manufacture of Ublituximab
Samsung Biologics, the world’s leading contract development and manufacturing organization and TG Therapeutics, announced an expansion of a large-scale contract manufacturing deal for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read